Skip to content

Patent Law Weblog

    • About

recent posts

  • Biofer S.P.A. v. Vifor (International) AG (Fed Cir. 2026)
  • Exelixis, Inc. v. MSN Laboratories Private Ltd. (Fed. Cir. 2026)
  • Patentees File Claim under 28 U.S.C. § 1498 before Court of Federal Claims, and Federal Government Files Motion to Dismiss under 28 U.S.C. § 1500
  • Amici Address Section 1498 Scope in Moderna COVID-19 Infringement Appeal: In Favor of Reversal
  • Amici Address Section 1498 Scope in Moderna COVID-19 Infringement Appeal: In Favor of Affirmance

about

  • Twitter
  • Facebook
  • Instagram

Conference & CLE Calendar

November 20, 2022

CalendarNovember 22, 2022 – "What Constitutes A 'Willing Licensee'?" (OxFirst) – 15:00 (GMT)

December 1-2, 2022 – International Summit on Biosimilars and Originator Biologics (American Conference Institute) – Munich Germany,

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
Like Loading…
Posted in Conferences & CLE’s

Leave a comment Cancel reply

←Webinar on What Constitutes A Willing Licensee
Alternative Reasoning for Supreme Court’s Life Sciences Subject Matter Eligibility Jurisprudence→

Blog at WordPress.com.

  • Comment
  • Reblog
  • Subscribe Subscribed
    • Patent Docs
    • Join 132 other subscribers
    • Already have a WordPress.com account? Log in now.
    • Patent Docs
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d